Searched for
PUNE GASTROINTESTINAL ISSUES
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%With the IT sector continuing to be the pain point for the market, it is essential to differentiate between what is leading to the fall in ...- Why children across India are getting ill more often, and how parents can respondIndia's children are facing a new health reality with frequent illnesses linked to climate change. Experts highlight how extreme weather an...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhile the ongoing correction has been brutal for all segments of the market, there are trading sessions when mid-caps have been punished mo...
- MNC stocks: Are some MNCs closer to an expansion inflection point? 9 non-FMCG MNC stocks, 5 with upside potential of over 25%Some time back, when Apple announced it intended to increase production in India, US President Trump said that he had directed the Apple CE...
- NRIs drive surge in India’s medical tourism with significant growth in health insurance adoptionMedical tourism in India is increasing. More NRIs are choosing India for treatment. This is due to lower costs and cultural familiarity. He...
- Time to make a distinction between FMCG & non-FMCG MNCs, second one may surprise: 7 MNC stocks with upside potential of 4% to 29%From a tobacco major to a railway bearing maker, some MNCs have seen parent companies selling stakes in their Indian entities, putting them...
- Is GBS a waterborne disease? Why Pune residents are alarmed amid rising cases of the rare illnessPune residents are alarmed over a potential water contamination following a surge in Guillain-Barre Syndrome cases. Investigation reveals t...
- Why this important ratio will help in better stock-picking. 7 stocks from different sectors which fit the bill of this less-used ratioThere is always the chance of going wrong in the market. So, caution and a long-term perspective should be your watchwords. But there are t...
- These large-caps have ‘strong buy’ & ‘buy’ recos and upside potential of more than 27%As the correction continues unabated, a divergence is emerging in what is happening to the Nifty and Sensex and what is happening in the en...
- Focussed ‘underlying business’ approach of long-term investing: 5 non-Nifty largecap stocks with upside potential of up to 39%Whether one accepts it or not, when someone uses the word large cap, first names which would come to mind would be nifty stocks. Because so...
- For the trader and investor in you: A collection of stocks suitable for trading and investing alikeIt is probably times like these, where valuations are high and the desire to trade and invest is also at a peak, one needs to set some rule...
- More than just an index and it's not Nifty: A collection of stocks suitable for trading and investing alikeOut of 50 stocks, only 5 of them have delivered negative returns in the last one year. Out of these 5 stocks, three stocks belong to one in...
- Probability favors them: A set of stocks to fulfill the desire of trader and investor in youTrading and investing are very different both in terms of skill sets, requirement of capital and finally the returns which one is able to g...
- Desire management, the quantitative way: A set of stocks for those who wish to do trade and invest at the same timeOut of 50 stocks, only 7 have delivered negative returns in the last one year. Out of these 7 stocks, four stocks belong to one industrial ...
- Midcap stocks with ‘strong buy’ & ‘buy’ recos can rally over 25%, according to analystsET screener powered by Refinitiv’s Stock Report Plus lists down quality stocks with high upside potential over the next 12 months, having a...
- Midcap stocks with ‘strong buy’ & ‘buy’ recos can rally over 25%, according to analystsET screener powered by Refinitiv’s Stock Report Plus lists down quality stocks with high upside potential over the next 12 months, having a...
- Midcap stocks with ‘strong buy’ & ‘buy’ recos can rally over 25%, according to analystsET screener powered by Refinitiv’s Stock Report Plus lists down quality stocks with high upside potential over the next 12 months, having a...
- Why India needs to back a new R&D treaty in health sectorLess than 10% of the $160 bn R&D spend is devoted to 90% of the world’s disease burden. India suffers, yet it is not being vocal for a glob...
Load More
